AOSLO Imaging for the Study of Cellular Alterations in Retinal Neurodegeneration
RETION
1 other identifier
interventional
260
0 countries
N/A
Brief Summary
Primary objective: \- Acquisition and analysis of images for non-medical purposes using the MONA IV system, an adaptive-optics-corrected scanning ophthalmoscope. Secondary objectives:
- To measure the reproducibility of assessments;
- To evaluate the detection of progressive changes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2026
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 21, 2026
CompletedFirst Posted
Study publicly available on registry
July 24, 2026
CompletedStudy Start
First participant enrolled
September 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2026
Study Completion
Last participant's last visit for all outcomes
April 1, 2030
July 24, 2026
July 1, 2026
Same day
July 21, 2026
July 21, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Proportion of images obtained with the MONA system deemed usable for the analysis of retinal microstructures.
Images are considered usable if they allow for: * visualization of retinal microstructures (yes/no); * measurement of cell density (yes/no); * measurement of vascular diameter (yes/no).
48 months
Study Arms (1)
MONA imaging system
EXPERIMENTALacquisition mode with MONA imaging system
Interventions
Eligibility Criteria
You may qualify if:
- Patients:
- subjects aged 10 to 79 years with a condition that may affect the inner retina (e.g., glaucoma, optic neuropathy, etc.)
- subjects aged 10 to 80 years with a condition that may affect the outer retina (e.g., AMD, retinitis pigmentosa, etc.)
- Male or female
- Covered by health insurance
- Healthy volunteers:
- subjects aged over 50 and under 80
- subjects aged over 18 and under 50
- Male or female
- Healthy subjects with no known condition that directly or indirectly affects the structure of the eye
- Covered by health insurance
You may not qualify if:
- For all subjects:
- Inability to remain motionless on a standard ophthalmic chin rest. RETION\_Protocol\_v2.0 dated June 10, 2026\_IDRCB: 2026-A00324-47 Page 10 of 44
- Subjects taking medications or suffering from a medical condition that could interfere with the evaluations planned under the protocol;
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 21, 2026
First Posted
July 24, 2026
Study Start (Estimated)
September 1, 2026
Primary Completion (Estimated)
September 1, 2026
Study Completion (Estimated)
April 1, 2030
Last Updated
July 24, 2026
Record last verified: 2026-07